Market Research Report
Electrophoresis Market by Product (Gel Electrophoresis (Horizontal & Vertical) (Agarose & Polyacrylamide), Capillary Electrophoresis, Reagents, Geldoc, Imaging), Application (Diagnostic, Reasearch, Quality Control), End User - Global Forecast to 2022
|Published by||MarketsandMarkets||Product code||330850|
|Published||Content info||246 Pages
Delivery time: 1-2 business days
|Electrophoresis Market by Product (Gel Electrophoresis (Horizontal & Vertical) (Agarose & Polyacrylamide), Capillary Electrophoresis, Reagents, Geldoc, Imaging), Application (Diagnostic, Reasearch, Quality Control), End User - Global Forecast to 2022|
|Published: June 12, 2017||Content info: 246 Pages||
The global electrophoresis market is projected to reach USD 2.80 billion by 2022, growing at a CAGR of 5.4% from 2017 to 2022. Factors responsible for the growth of this market include rising funding for electrophoresis techniques, growing focus on next-generation sequencing research, and rising incidence of chronic diseases. However, electrophoresis techniques involve time-consuming operations and offer limited sample analysis. These factors are expected to restrain the growth of the electrophoresis market during the forecast period.
On the basis of product, the electrophoresis market is segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and software. The gel documentation systems segment is expected to register the highest CAGR during the forecast period. The increasing demand for gel electrophoresis in proteomics research and personalized medicines is a major factor driving the growth of the overall gel electrophoresis market.
Based on end user, the electrophoresis market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and other end users. The hospitals & diagnostic centers segment is expected to grow at the highest CAGR during the forecast period. The growing prevalence of immunodeficiency diseases and rising incidence of serum protein disorders such as liver disease are also expected to propel the utilization of electrophoresis systems in hospitals and diagnostic centers during the forecast period.
North America held the largest share of the global electrophoresis market in 2016. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the growing proteomics and genomics research & increasing research funding, rising adoption of advanced electrophoresis techniques, increasing investments by pharmaceutical and biotechnology companies, and growing research collaborations and funding.
Break of primary participants was as mentioned below:
Some of the major market players in the electrophoresis market are Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).
The report analyzes the various types of systems & consumables and their adoption pattern. It aims at estimating the market size and future growth potential of the global electrophoresis market for different segments such as products, applications, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
Top 25 companies analyzed for this studies are - Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies Inc. (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Merck Millipore (U.S.), Harvard Bioscience, Inc. (U.S.), Shimadzu Corporation (Japan), Lonza Group Ltd. (Switzerland), Sebia Group (U.K.), C.B.S. Scientific Company, Inc. (U.S.), Helena Laboratories (U.S.), Takara Bio, Inc. (Japan), Cleaver Scientific Ltd (U.K.), Teledyne Technologies (U.S.), Endress+Hauser AG, (Germany), VWR International (U.S.), TBG Diagnostic Ltd (Australia), ATTO Corporation (Japan), Corning Inc. (U.S.), Ocimum Biosolutions, Inc. (U.S.), Sage Science (U.S.), Unimicro Technologies, Inc. (U.S.)
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.